| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |